... Diffuse indications 松散指示 ; 扩散指示 secondary indications 次要指示 false indications 伪显示 ...
基于68个网页-相关网页
·2,447,543篇论文数据,部分数据来源于NoteExpress
"Phase III trial results for secondary indications of marketed drugs that fail to achieve approval will also be posted, " Lilly stated in its press release.
FORBES: Silver Lining In Drug Disclosure
应用推荐
模块上移
模块下移
不移动